title: Androgenetic alopecia and current methods of treatment.
abstract: Androgenetic alopecia (AGA) is a common dermatological condition affecting both men and women. In the case of men, up to 30% over the age of 30 and more than 50% over the age of 50 are affected. AGA also affects women although clinical signs are usually milder and associated with diffuse thinning of the scalp hair. AGA invariably causes serious psychological problems especially in women. By far the most promising approaches to the treatment of baldness in men are drug therapies, such as topical minoxidil and finasteride administered systemically. Mild to moderate AGA in women can be treated with antiandrogens and/or topical minoxidil with good results in many cases.
authors.affiliation: Department of Dermatovenereology, Faculty of Medicine, Palacký University and University Hospital, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic. martina.bienova@fnol.cz
authors.forename: Martina
authors.initials: M
authors.lastname: Bienová
authors.forename: Renata
authors.initials: R
authors.lastname: Kucerová
authors.forename: Michala
authors.initials: M
authors.lastname: Fiurásková
authors.forename: Marián
authors.initials: M
authors.lastname: Hajdúch
authors.forename: Zdenìk
authors.initials: Z
authors.lastname: Koláŕ
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000505:Alopecia / Q000188:drug therapy* / Q000523:psychology / Q000601:surgery; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D018120:Finasteride / Q000627:therapeutic use*; D006197:Hair / Q000187:drug effects / Q000254:growth & development; D018859:Hair Follicle / Q000187:drug effects; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D018120:Finasteride; D008914:Minoxidil